Bilateral versus unilateral cases of chronic rhinosinusitis with nasal polyps have notable clinical and laboratory ...

Nasal polyps are linked to chronic inflammation from asthma, allergies, or infections. Medications can shrink nasal polyps. Surgery is often needed to remove them, but they can grow back unless ...

OBJECTIVE: Since some controversy exists concerning the frequency of inflammatory cells in nasal polyps, we have compared the frequency of tissue inflammatory cells (lymphocytes, neutrophils ...

Depemokimab is an inhibitor of IL-5, which is a key cytokine (protein) in type II inflammation. IL-5 is present at high ...

which said it remains committed to brining the drug to patients with the inflammatory condition, which results in the growth of nasal polyps in the nose that can sometimes require surgical ...

If nasal congestion persists, pus can accumulate in the sinuses and inflammation can spread If inflammation continues, polyps can also develop in the sinuses I thought, if this continues ...

Inflammation can occur because of conditions ... You could have an underlying medical condition, such as nasal polyps. Also, it’s best to talk with a doctor if you have severe or concerning ...

Get Instant Summarized Text (Gist) Asthma and antibiotic use at the time of initial endoscopic sinus surgery increase the likelihood of nasal polyp recurrence, necessitating revision surgery. Age ...

Study uncovers a pathogenic subset of memory T-cells that promote tissue inflammation and highlights a potential target for treating nasal polyps and other inflammatory airway diseases.

EMA accepts for review GSK’s MAA for depemokimab for use in asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 09:00 Hrs [IST] GSK plc announced ...

GSK announces depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 17:00 Hrs [IS ...